Molecular Mechanisms that Regulate Epidermal Growth Factor Receptor Inactivation
2008
Understanding How EGFR is Inactivated
publication
Evidence: moderate
Author Information
Author(s): Brian P. Ceresa, Phillip A. Vanlandingham
Primary Institution: University of Oklahoma Health Sciences Center
Hypothesis
It remains unclear whether the uncontrolled EGFR activity leads to cell transformation or is a consequence of cell transformation.
Conclusion
The study discusses the molecular mechanisms that regulate EGFR inactivation and their potential as therapeutic targets for inhibiting EGFR signaling.
Supporting Evidence
- EGFR overexpression is associated with several types of cancer.
- Monoclonal antibodies and tyrosine kinase inhibitors are current strategies to inhibit EGFR.
- EGFR signaling can be terminated through various mechanisms including receptor degradation.
Takeaway
EGFR is a protein that helps cells grow, but when it's too active, it can cause cancer. This study looks at how to turn off EGFR to help treat cancer.
Limitations
Current therapies targeting EGFR have only been approved for a limited number of cancers and have unpleasant side effects.
Want to read the original?
Access the complete publication on the publisher's website